Company Seeks Approval for New Cow Feed Coating
Published Date: 7/24/2026
Proposed Rule
Summary
Evonik Corporation has asked the FDA to approve ethyl cellulose as a safe binder and coating for amino acids in food for ruminant animals like cows and sheep. This change could improve animal feed quality without extra costs or delays, with the petition officially filed on June 16, 2026. Farmers and feed producers should keep an eye out as this could soon become part of the rules.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Ethyl cellulose for ruminant feed
The FDA filed a petition on June 16, 2026, asking to allow ethyl cellulose to be used as a binder and coating on amino acids in food for ruminant animals under 21 CFR part 573. If approved, this would change the rules about what can be added to feed for animals like cows and sheep.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-14985, Medical Devices; Immunology and Microbiology Devices; Classification of the Over-the-Counter Test To Detect SARS-CoV-2 From Clinical Specimens
The FDA is officially putting over-the-counter COVID-19 tests into a safer, easier-to-manage category called Class II, starting July 24, 2026. This change helps make sure these tests work well and are safe, while also making it simpler for companies to bring new tests to you. If you’re a test maker or a user, expect better access and less red tape, with no extra costs announced.
2026-14986, Medical Devices; General Hospital and Personal Use Devices; Classification of the Diabetes Digital Behavioral Therapeutic Device
The FDA has officially placed the diabetes digital behavioral therapeutic device into Class II, meaning it now has special safety rules but fewer regulatory hurdles. This change helps patients get access to this innovative device faster and ensures it’s safe and effective. The new classification took effect on July 24, 2026, with benefits starting from July 7, 2023, making it easier and potentially cheaper for makers to bring these devices to market.
2026-14984, Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Prognostic Test for Assessment of Chronic Kidney Disease Progression
The FDA is officially putting a special kidney disease test into Class II, meaning it’s safe and effective but with some extra rules to keep it that way. This change helps patients get access to this cool new test faster by cutting down red tape. The new classification is effective July 24, 2026, and could save companies time and money while making sure the test works well.
2026-14989, Francis Esteban Matos: Final Debarment Order
Francis Esteban Matos is banned for 5 years from importing any drugs into the U.S. because he was convicted of a serious crime related to drug importation. He didn’t respond to the FDA’s notice, so the ban started on July 24, 2026. Matos can apply to end this ban anytime, but he must follow specific rules to do so.
Previous / Next Documents
Previous: 2026-15018, Pacific Island Fisheries; 2026-2028 Annual Catch Limits and Accountability Measures for Deepwater Shrimp and Precious Coral Fisheries in Hawaii
Starting in 2026, Hawaii’s deepwater shrimp and precious coral fisheries will follow set catch limits to keep these ocean treasures safe and thriving through 2028. If fishermen catch too much over three years, the allowed catch will be lowered the next year to protect the species. This plan helps fishermen and the environment stay in balance without changing current rules, and public comments are open until August 24, 2026.
Next: 2026-15029, Amendment of Class E Airspace; Alma, MI; correction
The FAA fixed a mistake in a recent rule about changing the airspace around Alma, Michigan. They accidentally titled the document with the wrong city, Bedford, Indiana, so now they’re correcting it and giving folks more time to share their thoughts until September 8, 2026. This update mainly affects pilots and local air traffic but won’t cost anyone extra money.